163 related articles for article (PubMed ID: 12123338)
1. Gemcitabine, epirubicin and paclitaxel: pharmacokinetic and pharmacodynamic interactions in advanced breast cancer.
Fogli S; Danesi R; Gennari A; Donati S; Conte PF; Del Tacca M
Ann Oncol; 2002 Jun; 13(6):919-27. PubMed ID: 12123338
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and pharmacodynamics of combination chemotherapy with paclitaxel and epirubicin in breast cancer patients.
Danesi R; Innocenti F; Fogli S; Gennari A; Baldini E; Di Paolo A; Salvadori B; Bocci G; Conte PF; Del Tacca M
Br J Clin Pharmacol; 2002 May; 53(5):508-18. PubMed ID: 11994057
[TBL] [Abstract][Full Text] [Related]
3. Dose-finding study and pharmacokinetics of epirubicin and paclitaxel over 3 hours: a regimen with high activity and low cardiotoxicity in advanced breast cancer.
Conte PF; Baldini E; Gennari A; Michelotti A; Salvadori B; Tibaldi C; Danesi R; Innocenti F; Gentile A; Dell'Anna R; Biadi O; Mariani M; Del Tacca M
J Clin Oncol; 1997 Jul; 15(7):2510-7. PubMed ID: 9215819
[TBL] [Abstract][Full Text] [Related]
4. Drug distribution and pharmacokinetic/pharmacodynamic relationship of paclitaxel and gemcitabine in patients with non-small-cell lung cancer.
Fogli S; Danesi R; De Braud F; De Pas T; Curigliano G; Giovannetti G; Del Tacca M
Ann Oncol; 2001 Nov; 12(11):1553-9. PubMed ID: 11822754
[TBL] [Abstract][Full Text] [Related]
5. A phase II trial of dose-dense neoadjuvant gemcitabine, epirubicin, and albumin-bound paclitaxel with pegfilgrastim in the treatment of patients with locally advanced breast cancer.
Yardley DA; Zubkus J; Daniel B; Inhorn R; Lane CM; Vazquez ER; Naot Y; Burris HA; Hainsworth JD
Clin Breast Cancer; 2010 Oct; 10(5):367-72. PubMed ID: 20670921
[TBL] [Abstract][Full Text] [Related]
6. Gemcitabine and paclitaxel: pharmacokinetic and pharmacodynamic interactions in patients with non-small-cell lung cancer.
Kroep JR; Giaccone G; Voorn DA; Smit EF; Beijnen JH; Rosing H; van Moorsel CJ; van Groeningen CJ; Postmus PE; Pinedo HM; Peters GJ
J Clin Oncol; 1999 Jul; 17(7):2190-7. PubMed ID: 10561275
[TBL] [Abstract][Full Text] [Related]
7. The gemcitabine/epirubicin/paclitaxel combination in advanced breast cancer.
Gennari A; Donati S; Danesi R; Fogli S; Orlandini C; Del Tacca M; Conte PF
Semin Oncol; 2000 Feb; 27(1 Suppl 2):14-9. PubMed ID: 10697031
[TBL] [Abstract][Full Text] [Related]
8. Phase I and pharmacokinetic study of docetaxel in combination with epirubicin and cyclophosphamide in advanced cancer: dose escalation possible with granulocyte colony-stimulating factor, but not with prophylactic antibiotics.
Rischin D; Ackland SP; Smith J; Garg MB; Clarke S; Millward MJ; Toner GC; Zalcberg J
Ann Oncol; 2002 Nov; 13(11):1810-8. PubMed ID: 12419756
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic optimisation of treatment schedules for anthracyclines and paclitaxel in patients with cancer.
Danesi R; Conte PF; Del Tacca M
Clin Pharmacokinet; 1999 Sep; 37(3):195-211. PubMed ID: 10511918
[TBL] [Abstract][Full Text] [Related]
10. The gemcitabine/epirubicin/paclitaxel trials in advanced breast cancer.
Conte P; Salvadori B; Donati S; Gennari A; Cetto GL; Molino A; Crino L; Mazzoni F; Galligioni E; Mansutti M
Oncology (Williston Park); 2001 Feb; 15(2 Suppl 3):41-3. PubMed ID: 11252889
[TBL] [Abstract][Full Text] [Related]
11. A phase I and pharmacokinetic study of paclitaxel and epirubicin in advanced cancer.
Rischin D; Webster LK; Millward MJ; Toner GC; Nawaratne S; Ganju V; Francis P; Bishop JF
Invest New Drugs; 1999; 17(1):73-80. PubMed ID: 10555125
[TBL] [Abstract][Full Text] [Related]
12. Clinical and pharmacologic study of the epirubicin and paclitaxel combination in women with metastatic breast cancer.
Grasselli G; Viganò L; Capri G; Locatelli A; Tarenzi E; Spreafico C; Bertuzzi A; Giani A; Materazzo C; Cresta S; Perotti A; Valagussa P; Gianni L
J Clin Oncol; 2001 Apr; 19(8):2222-31. PubMed ID: 11304775
[TBL] [Abstract][Full Text] [Related]
13. Gemcitabine plus epirubicin plus taxol (GET) in advanced breast cancer: a phase II study.
Conte PF; Gennari A; Donati S; Salvadori B; Baldini E; Bengala C; Pazzagli I; Orlandini C; Danesi R; Fogli S; Del Tacca M
Breast Cancer Res Treat; 2001 Jul; 68(2):171-9. PubMed ID: 11688520
[TBL] [Abstract][Full Text] [Related]
14. Phase II trial of gemcitabine/doxorubicin/paclitaxel administered every other week in patients with metastatic breast cancer.
Sánchez-Rovira P; Jaén A; González E; Porras I; Dueñas MR; Medina B; Mohedano N; Fernández M; Martos M; Lozano A
Clin Breast Cancer; 2000 Oct; 1(3):226-32. PubMed ID: 11899647
[TBL] [Abstract][Full Text] [Related]
15. Sequence effect of epirubicin and paclitaxel treatment on pharmacokinetics and toxicity.
Venturini M; Lunardi G; Del Mastro L; Vannozzi MO; Tolino G; Numico G; Viale M; Pastrone I; Angiolini C; Bertelli G; Straneo M; Rosso R; Esposito M
J Clin Oncol; 2000 May; 18(10):2116-25. PubMed ID: 10811677
[TBL] [Abstract][Full Text] [Related]
16. Phase I and pharmacokinetic study of two sequences of gemcitabine and docetaxel administered weekly to patients with advanced cancer.
Bhargava P; Marshall JL; Fried K; Williams M; Lefebvre P; Dahut W; Hanfelt J; Gehan E; Figuera M; Hawkins MJ; Rizvi NA
Cancer Chemother Pharmacol; 2001 Aug; 48(2):95-103. PubMed ID: 11561784
[TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant dose-dense gemcitabine plus docetaxel and vinorelbine plus epirubicin for operable breast cancer: improved prognosis in triple-negative tumors.
Medioni J; Huchon C; Le Frere-Belda MA; Hofmann H; Bats AS; Eme D; Andrieu JM; Oudard S; Lecuru F; Levy E
Drugs R D; 2011; 11(2):147-57. PubMed ID: 21679005
[TBL] [Abstract][Full Text] [Related]
18. Gemcitabine plus dose-escalated epirubicin in advanced breast cancer: results of a phase I study.
Lüftner D; Flath B; Akrivakis C; Mergenthaler HG; Ohnmacht U; Arning M; Possinger K
Invest New Drugs; 1998; 16(2):141-6. PubMed ID: 9848577
[TBL] [Abstract][Full Text] [Related]
19. A phase I and pharmacologic study of capecitabine and paclitaxel in breast cancer patients.
Villalona-Calero MA; Blum JL; Jones SE; Diab S; Elledge R; Khoury P; Von Hoff D; Kraynak M; Moczygemba J; Kromelis P; Griffin T; Rowinsky EK
Ann Oncol; 2001 May; 12(5):605-14. PubMed ID: 11432617
[TBL] [Abstract][Full Text] [Related]
20. Gemcitabine pharmacokinetics and interaction with paclitaxel in patients with advanced non-small-cell lung cancer.
Shord SS; Faucette SR; Gillenwater HH; Pescatore SL; Hawke RL; Socinski MA; Lindley C
Cancer Chemother Pharmacol; 2003 Apr; 51(4):328-36. PubMed ID: 12721761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
